A&W Revenue Royalties Income Fund (T.AW.UN) hit a new 52-week high of $36.65 Tuesday. A&W Revenue Royalties Income Fund and A ...

Canadian equities started mixed on Tuesday. The top gainers were Capped Consumer Staples, Capped Utilities and Capped Real Estate indices. Capped Energy, Capped Materials and Renewable Energy and ...

Glaucoma Therapeutics MarketThe global glaucoma therapeutics market is projected to be valued at approximately USD 6.9 million in 2022, with expectations to expand at a compound annual growth rate ...

Eleven months after the zoo sent its three wildly popular pandas — Mei Xiang, Tian Tian and their cub Xiao Qi Ji — back to ...

We are thrilled to welcome Dr. Wechsler to our Board of Directors,” said Dr. Carl Goldfischer, Chair of the Board of Galecto. “Amy is a distinguished physician who has board certification in both ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

In the health care industry, the private equity firm has put in over $18 billion in companies including Bausch + Lomb Corp., Ensemble Healthcare Partners and Global Healthcare Exchange. The private ...

Dovid Efune is in exclusive negotiations to acquire the UK's Telegraph for $550 million. Rachel Reeves has reduced the ...

After kicking off a sales process roughly a month ago, eye-health firm Bausch + Lomb has stirred up significant interest from ...

It was quite a busy and eventful day for the company.

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...